Among strategies aimed at intercepting C3, derivatives of the compstatin family and soluble CR1 displayed favorable effects in preclinical models and in patients with age-related macular degeneration or C3 glomerulopathy58, 59, 60. The gene discussed is CR1; the disease is age-related macular degeneration.